Next-generation sequencing has revolutionized molecular testing. Lung Cancer has one of the highest incidence rates with rapidly evolving therapeutics. Join us at this exclusive event as we explore this the ever-changing landscape of Lung Cancer. At the same time, we are excited to share the launch of the NEXUS initiative that is supporting Lung Cancer testing in collaboration with our Pharmaceutical partners (AstraZaneca and Pfizer) as part of the agenda on this day!

There will be a panel discussion after the presentation and opportunity to interact with the speakers as well as a live Q&A session. Participants are encouraged to come with questions.
This is one of the our APJ oncology user meeting, which will be held as part of OncomineWorld virtual environment. In this virtual environment, you will have the opportunity to:
Explore the NGS Oncology Application Hall and its many specialty booth-labs including immuno-oncology research, emerging NSCLC biomarkers, liquid biopsy, PIK3CA research testing, and hemato-oncology research.
Visit our virtual lab to experience the new world of easy and fast NGS - the Ion Torrent Genexus System - and become familiar with our well-proven workhorse, the Ion Torrent GeneStudio system, with its many applications.
Visit the Precision Oncology Hall to access videos, posters and more on the future potential of NGS in the clinic.
Register today!
Professor of Medicine and Chest Physician, University Malaya Medical Centre/Faculty of Medicine, University of Malaya
Senior Consultant Pathologist and Laboratory Director
Co-founder and President of Lung Cancer Network Malaysia (LCNM)
Associate Professor